NEOPAR

Canine Parvovirus Vaccine – Modified Live Virus

Features

Core Disease Protection
Induces protection against the most lethal and prevalent viral disease of dogs, canine parvovirus

Maximum Protection
Contains a High Antigen Mass (more vaccine units per dose) which results in:
- Short period from vaccination to protection
- Higher level of protection (many times greater than the level needed for basic protection)
- Long duration of immunity

Early Age Protection
Stimulates antibody production in the presence of existing maternal antibodies

First Dose Protection
- Antibody production begins after the first dose. Other canine parvovirus vaccines require two or three doses to stimulate an initial antibody response.

Single Antigen Vaccine
- Eliminates the need to use complex combination adult vaccines (commonly referred to as 5-way vaccines) in the young puppy
- More efficient in stimulating antibody production than complex combination vaccines

Safety
- Found to be safe for use in young puppies
- Less likely to produce a vaccine reaction than complex combination vaccines